Explore NIH Technologies

Explore work by over 1,500 NIH researchers   |   Available for Licensing & Collaboration


Explore Featured Research

Get updates on the latest and most exciting research coming out of NIH...

Read More >

Explore Featured Products

Novel and interesting products coming to market through NIH inventions and partnerships...

Read More >

A monoclonal antibody therapy discovery that arose from a 2005 research collaboration between scientists at the National Cancer Institute (NCI) and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) has again been designated for human compassionate therapeutic use – this
Each year NIH Technology Transfer releases a list of the top 20 royalty-on-sales grossing products of the year based upon license agreements to inventions made by the NIH intramural research program. The list is broken down into four categories: vaccines and therapeutics, diagnostics
A novel anti-cancer therapy to target the Proviral Integration of the Moloney murine leukemia virus (PIM) kinases is available for licensing and co-development. PIM kinases are overexpressed in many solid cancers, which is predictive of poor survival in multiple cancer types. NIH inventors have